96 related articles for article (PubMed ID: 9209728)
1. Evaluation of cranial electrostimulation therapy on short-term smoking cessation.
Pickworth WB; Fant RV; Butschky MF; Goffman AL; Henningfield JE
Biol Psychiatry; 1997 Jul; 42(2):116-21. PubMed ID: 9209728
[TBL] [Abstract][Full Text] [Related]
2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
3. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
4. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption.
Amiaz R; Levy D; Vainiger D; Grunhaus L; Zangen A
Addiction; 2009 Apr; 104(4):653-60. PubMed ID: 19183128
[TBL] [Abstract][Full Text] [Related]
5. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
7. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
[TBL] [Abstract][Full Text] [Related]
8. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial.
Rennard SI; Glover ED; Leischow S; Daughton DM; Glover PN; Muramoto M; Franzon M; Danielsson T; Landfeldt B; Westin A
Nicotine Tob Res; 2006 Aug; 8(4):555-64. PubMed ID: 16920653
[TBL] [Abstract][Full Text] [Related]
11. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J; Säwe U
J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
[TBL] [Abstract][Full Text] [Related]
12. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
[TBL] [Abstract][Full Text] [Related]
13. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Cárdenas L; Busto UE; MacDonald A; Corrigall WA
Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
[TBL] [Abstract][Full Text] [Related]
14. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
15. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Rose JE; Herskovic JE; Behm FM; Westman EC
Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
[TBL] [Abstract][Full Text] [Related]
18. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
Cousins MS; Stamat HM; de Wit H
Nicotine Tob Res; 2001 May; 3(2):123-9. PubMed ID: 11403726
[TBL] [Abstract][Full Text] [Related]
19. Clinical laboratory evaluation of potential reduced exposure products for smokers.
Breland AB; Kleykamp BA; Eissenberg T
Nicotine Tob Res; 2006 Dec; 8(6):727-38. PubMed ID: 17132520
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.
Ornish SA; Zisook S; McAdams LA
Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]